Nanoclays mediate stem cell differentiation and mineralized ECM formation on biopolymer scaffolds

Journal of Biomedical Materials Research - Part A

Volumn 101 A, Issue 9, 2013, Pages 2644-2660

  Ambre, Avinash H ^a   Katti, Dinesh R ^a   Katti, Kalpana S ^a  

^a North Dakota State University   (United States)

Author keywords

chitosan; human mesenchymal stem cells; hydroxyapatite; nanocomposite; polygalacturonic acid; scaffold

Indexed keywords

BONE TISSUE ENGINEERING; HUMAN MESENCHYMAL STEM CELLS; HUMAN MESENCHYMAL STEM CELLS (HMSCS); HYDROXYAPATITE (HAP); OSTEOGENIC SUPPLEMENTS; PHASE-CONTRAST IMAGE; POLYGALACTURONIC ACID; STEM CELL DIFFERENTIATION;

BIOLOGICAL MATERIALS; BIOMINERALIZATION; BIOMOLECULES; BONE; CHITOSAN; COMPOSITE FILMS; HYDROXYAPATITE; NANOCOMPOSITES; SCAFFOLDS; STEM CELLS;

SCAFFOLDS (BIOLOGY);

ALIZARIN RED S; BIOPOLYMER; CHITOSAN; HYDROXYAPATITE; NANOCLAY; NANOMATERIAL; POLYGALACTURONIC ACID; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC FORCE MICROSCOPY; BIOMINERALIZATION; BONE CONDUCTION; BONE TISSUE; CELL DIFFERENTIATION; CELL VIABILITY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PHASE CONTRAST MICROSCOPE; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING;

CHITOSAN; HUMAN MESENCHYMAL STEM CELLS; HYDROXYAPATITE; NANOCOMPOSITE; POLYGALACTURONIC ACID; SCAFFOLD;

ALKALINE PHOSPHATASE; BENTONITE; BIOCOMPATIBLE MATERIALS; BIOMIMETIC MATERIALS; BIOPOLYMERS; CELL DIFFERENTIATION; CELLS, CULTURED; CHITOSAN; DURAPATITE; EXTRACELLULAR MATRIX; HUMANS; MATERIALS TESTING; MESENCHYMAL STROMAL CELLS; MINERALS; NANOSTRUCTURES; OSTEOGENESIS; PECTINS; TISSUE SCAFFOLDS;

EID: 84880597334     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34561     Document Type: Article

References (70)

1. Langer R, Vacanti JP., Tissue Engineering., Science 1993; 260: 920-926.
2. Elisseeff J, Ferran A, Hwang S, Varghese S, Zhang Z,. The role of biomaterials in stem cell differentiation: Applications in the Musculoskeletal System. Stem Cells Dev 2006; 15: 295-303.
3. Polak JM, Bishop AE,. Stem cells and tissue engineering: past, present, and future. Ann N Y Acad Sci 2006; 1068: 352-366.
4. Leo AJ, Grande DA,. Mesenchymal stem cells in tissue engineering. Cells Tissues Organs 2006; 183: 112-122.
5. Marolt D, Knezevic M, Vunjak-Novakovic G,. Bone tissue engineering with human stem cells. Stem Cell Res Ther 2010; 1: 10.
6. Chen F, Tuan R,. Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther 2008; 10: 223.
7. Shi Y, Hu G, Su J, Li W, Chen Q, Shou P, Xu C, Chen X, Huang Y, Zhu Z, Huang X, Han X, Xie N, Ren G,. Mesenchymal stem cells: A new strategy for immunosuppression and tissue repair. Cell Res 2010; 20: 510-518.
8. Otto W, Wright N,. Mesenchymal stem cells: From experiment to clinic. Fibrogenesis Tissue Repair 2011; 4: 20.
9. Uccelli A, Pistoia V, Moretta L,. Mesenchymal stem cells: A new strategy for immunosuppression? Trends Immunol 2007; 28: 219-226.
10. Bose S, Tarafder S,. Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: A review. Acta Biomater 2012; 8: 1401-1421.
11. Zhou H, Lee J,. Nanoscale hydroxyapatite particles for bone tissue engineering. Acta Biomater 2011; 7: 2769-2781.
12. Vallet-Regi M,. Ceramics for medical applications. J Chem Soc, Dalton Trans 2001: 97-108.
13. Chan CK, Kumar TSS, Liao S, Murugan R, Ngiam M, Ramakrishman S,. Biomimetic nanocomposites for bone graft applications. Nanomedicine 2006; 1: 177-188.
14. Patel N, Best SM, Bonfield W, Gibson IR, Hing KA, Damien E, Revell PA,. A comparative study on the in vivo behavior of hydroxyapatite and silicon substituted hydroxyapatite granules. J Mater Sci: Mater Med 2002; 13: 1199-1206.
15. Vallet-Regi M,. Revisiting ceramics for medical applications. Dalton Trans 2006: 5211-5220.
16. Botelho CM, Brooks RA, Best SM, Lopes MA, Santos JD, Rushton N, Bonfield W,. Human osteoblast response to silicon-substituted hydroxyapatite. J Biomed Mater Res Part A 2006; 79A: 723-730.
17. Sinha Ray S, Okamoto M,. Polymer/layered silicate nanocomposites: A review from preparation to processing. Prog Polym Sci 2003; 28: 1539-1641.
18. Goldberg M, Langer R, Jia XQ,. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed 2007; 18: 241-268.
19. Christenson EM, Anseth KS, van den Beucken L, Chan CK, Ercan B, Jansen JA, Laurencin CT, Li WJ, Murugan R, Nair LS, Ramakrishna S, Tuan RS, Webster TJ, Mikos AG,. Nanobiomaterial applications in orthopedics. J Orthop Res 2007; 25: 11-22.
20. Stevens MM, George JH,. Exploring and engineering the cell surface interface. Science 2005; 310: 1135-1138.
21. Okada A, Kawasumi M, Usuki A, Kojima Y, Kurauchi T, Kamigaito O,. Synthesis and properties of nylon-6/clay hybrids. In:, D. W. Schaefer, &, J. E. Mark, editors. Polymer Based Molecular Composites, vol. 171. MRS Symposium Proceedings; 1990. p 45-50.
22. Giannelis EP,. Polymer layered silicate nanocomposites. Adv Mater 1996; 8: 29-35.
23. Chen GX, Hao GJ, Guo TY, Song MD, Zhang BH,. Structure and mechanical properties of poly(3-hydroxybutyrateco-3-hydroxyvalerate) (PHBV)/clay nanocomposites. J Mater Sci Lett 2002; 21: 1587-1589.
24. Pramanik M, Srivastava SK, Samantaray BK, Bhowmick AK,. Rubber-clay nanocomposite by solution blending. J Appl Polym Sci 2003; 87: 2216-2220.
25. Messersmith PB, Giannelis EP,. Synthesis and barrier properties of poly(ε-caprolactone)-layered silicate nanocomposites. J Polym Sci Part A: Polym Chem 1995; 33: 1047-1057.
26. Yano K, Usuki A, Okada A, Kurauchi T, Kamigaito O,. Synthesis and properties of polyimide-clay hybrid. J Polym Sci Part A: Polym Chem 1993; 31: 2493-2498.
27. Bharadwaj RK,. Modeling the barrier properties of polymer-layered silicate nanocomposites. Macromolecules 2001; 34: 9189-9192.
28. Gilman JW,. Flammability and thermal stability studies of polymer layered-silicate (clay) nanocomposites. Appl Clay Sci 1999; 15: 31-49.
29. Gilman JW, Jackson CL, Morgan AB, Harris R,. Flammability properties of polymer-layered-silicate nanocomposites. Polypropylene and polystyrene nanocomposites. Chem Mater 2000; 12: 1866-1873.
30. Katti DR, Schmidt SR, Ghosh P, Katti KS,. Modeling the response of pyrophyllite interlayer to applied stress using steered molecular dynamics. Clay Clay Miner 2005; 53: 171-178.
31. Katti DR, Schmidt SR, Ghosh P, Katti KS,. Molecular modeling of the mechanical behavior and interactions in dry and slightly hydrated sodium montmorillonite interlayer. Can Geotech J 2007; 44: 425-435.
32. Katti DR, Matar MI, Katti KS, Amarasinghe PM,. Multiscale modeling of swelling clays: A computational and experimental approach. KSCE J Civil Eng 2009; 13: 243-255.
33. Schmidt SR, Katti DR, Ghosh P, Katti KS,. Evolution of mechanical response of sodium montmorillonite interlayer with increasing hydration by molecular dynamics. Langmuir 2005; 21: 8069-8076.
34. Amarasinghe PM, Katti KS, Katti DR,. Molecular hydraulic properties of montmorillonite: A polarized Fourier transform infrared spectroscopic study. Appl Spectrosc 2008; 62: 1303-1313.
35. Amarasinghe PM, Katti KS, Katti DR,. Nature of organic fluid-montmorillonite interactions: An FTIR spectroscopic study. J Colloid Interface Sci 2009; 337: 97-105.
36. Amarasinghe PM, Katti KS, Katti DR,. Insight into role of clay-fluid molecular interactions on permeability and consolidation behavior of Na-montmorillonite swelling clay. J Geotech Geoenviron Eng 2012; 138: 138-146.
37. Sikdar D, Pradhan SM, Katti DR, Katti KS, Mohanty B,. Altered phase model for polymer clay nanocomposites. Langmuir 2008; 24: 5599-5607.
38. Sikdar D, Katti DR, Katti KS,. The role of interfacial interactions on the crystallinity and nanomechanical properties of clay-polymer nanocomposites: A molecular dynamics study. J Appl Polym Sci 2008; 107: 3137-3148.
39. Sikdar D, Katti D, Katti K, Mohanty B,. Influence of backbone chain length and functional groups of organic modifiers on crystallinity and nanomechanical properties of intercalated clay-polycaprolactam nanocomposites. Int J Nanotechnol 2009; 6: 468-492.
40. Katti DR, Ghosh P, Schmidt S, Katti KS,. Mechanical properties of the sodium montmorillonite interlayer intercalated with amino acids. Biomacromolecules 2005; 6: 3276-3282.
41. Viseras C, Aguzzi C, Cerezo P, Lopez-Galindo A,. Uses of clay minerals in semisolid health care and therapeutic products. Appl Clay Sci 2007; 36: 37-50.
42. Forni F, Iannuccelli V, Coppi G, Bernabei MT,. Effect of montmorillonite on drug release from polymeric matrices. Arch Pharm 1989; 322: 789-793.
43. Lee W-F, Fu Y-T,. Effect of montmorillonite on the swelling behavior and drug-release behavior of nanocomposite hydrogels. J Appl Polym Sci 2003; 89: 3652-3660.
44. Lin F-H, Chen C-H, Cheng WTK, Kuo T-F,. Modified montmorillonite as vector for gene delivery. Biomaterials 2006; 27: 3333-3338.
45. Takahashi T, Yamada Y, Kataoka K, Nagasaki Y,. Preparation of a novel PEG-clay hybrid as a DDS material: Dispersion stability and sustained release profiles. J Control Release 2005; 107: 408-416.
46. Wang X, Du Y, Luo J,. Biopolymer/montmorillonite nanocomposite: Preparation, drug-controlled release property and cytotoxicity. Nanotechnology 2008; 19: 065707.
47. Sun B, Ranganathan B, Feng S-S,. Multifunctional poly(d,l-lactide-co- glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer. Biomaterials 2008; 29: 475-486.
48. Carretero MI,. Clay minerals and their beneficial effects upon human health. A review. Appl Clay Sci 2002; 21: 155-163.
49. Lin K-F, Hsu C-Y, Huang T-S, Chiu W-Y, Lee Y-H, Young T-H,. A novel method to prepare chitosan/montmorillonite nanocomposites. J Appl Polym Sci 2005; 98: 2042-2047.
50. Marras SI, Kladi KP, Tsivintzelis I, Zuburtikudis I, Panayiotou C,. Biodegradable polymer nanocomposites: The role of nanoclays on the thermomechanical characteristics and the electrospun fibrous structure. Acta Biomater 2008; 4: 756-765.
51. Zheng JP, Wang CZ, Wang XX, Wang HY, Zhuang H, Yao KD,. Preparation of biomimetic three-dimensional gelatin/montmorillonite-chitosan scaffold for tissue engineering. React Funct Polym 2007; 67: 780-788.
52. Depan D, Kumar AP, Singh RP,. Cell proliferation and controlled drug release studies of nanohybrids based on chitosan-g-lactic acid and montmorillonite. Acta Biomater 2009; 5: 93-100.
53. Katti KS, Katti DR, Dash R,. Synthesis and characterization of a novel chitosan/montmorillonite/hydroxyapatite nanocomposite for bone tissue engineering. Biomed Mater 2008; 3: 12.
54. Mieszawska AJ, Llamas JG, Vaiana CA, Kadakia MP, Naik RR, Kaplan DL,. Clay enriched silk biomaterials for bone formation. Acta Biomater 2011; 7: 3036-3041.
55. Katti KS, Ambre AH, Peterka N, Katti DR,. Use of unnatural amino acids for design of novel organomodified clays as components of nanocomposite biomaterials. Philos Transact A Math Phys Eng Sci 2010; 368: 1963-1980.
56. Ambre AH, Katti KS, Katti DR,. Nanoclay based composite scaffolds for bone tissue engineering applications. J Nanotechnol Eng Med 2010; 1: 031013-031019.
57. Ambre A, Katti KS, Katti DR,. In situ mineralized hydroxyapatite on amino acid modified nanoclays as novel bone biomaterials. Mater Sci Eng: C 2011; 31: 1017-1029.
58. Khanna R, Katti KS, Katti DR,. Bone nodules on chitosan-polygalacturonic acid-hydroxyapatite nanocomposite films mimic hierarchy of natural bone. Acta Biomater 2011; 7: 1173-1183.
59. Verma D, Katti KS, Katti DR,. Osteoblast adhesion, proliferation and growth on polyelectrolyte complex-hydroxyapatite nanocomposites. Philos Transact A Math Phys Eng Sci 2010; 368: 2083-2097.
60. Filipak M, Estervig DN, Tzen C-Y, Minoo P, Hoerl BJ, Maercklein PB, Zschunke MA, Edens M, Scott RE,. Integrated control of proliferation and differentiation of mesenchymal stem cells. Environ Health Perspect 1989; 80: 117-125.
61. Plaisant M, Giorgetti-Peraldi S, Gabrielson M, Loubat A, Dani C, Peraldi P,. Inhibition of Hedgehog signaling decreases proliferation and clonogenicity of human mesenchymal stem cells. PLoS One 2011; 6: e16798.
62. Verma D, Katti KS, Katti DR,. Polyelectrolyte-complex nanostructured fibrous scaffolds for tissue engineering. Mater Sci Eng: C 2009; 29: 2079-2084.
63. Asumda F, Chase P,. Age-related changes in rat bone-marrow mesenchymal stem cell plasticity. BMC Cell Biol 2011; 12: 1-11.
64. Guzmán-Morales J, El-Gabalawy H, Pham MH, Tran-Khanh N, McKee MD, Wu W, Centola M, Hoemann CD,. Effect of chitosan particles and dexamethasone on human bone marrow stromal cell osteogenesis and angiogenic factor secretion. Bone 2009; 45: 617-626.
65. Lian JB, Stein GS,. Concepts of osteoblast growth and differentiation: basis for modulation of bone cell development and tissue formation. Crit Rev Oral Biol Med 1992; 3: 269-305.
66. Hauschka PV, Lian JB, Cole DE, Gundberg CM,. Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone. Physiol Rev 1989; 69: 990-1047.
67. Kim E-K, Lim S, Park J-M, Seo JK, Kim JH, Kim KT, Ryu SH, Suh P-G,. Human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by AMP-activated protein kinase. J Cell Physiol 2012; 227: 1680-1687.
68. Stein GS, Lian JB,. Molecular mechanisms mediating proliferation/ differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 1993; 14: 424-442.
69. Roman J, Cabanas MV, Pena J, Vallet-Regi M,. Control of the pore architecture in three-dimensional hydroxyapatite-reinforced hydrogel scaffolds. Sci Technol Adv Mater 2011; 12: 045003.
70. Jana S, Florczyk SJ, Leung M, Zhang M,. High-strength pristine porous chitosan scaffolds for tissue engineering. J Mater Chem 2012; 22: 6291-6299.